Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Department of Radiology and Imaging Sciences, Indiana University School of Medicine, 550 N. University Blvd. Suite 0663, Indianapolis, IN, 46202, USA.
Abdom Radiol (NY). 2023 Oct;48(10):3162-3173. doi: 10.1007/s00261-023-04000-1. Epub 2023 Jul 12.
To determine the diagnostic performance of parenchymal MRI features differentiating CP from controls.
This prospective study performed abdominal MRI scans at seven institutions, using 1.5 T Siemens and GE scanners, in 50 control and 51 definite CP participants, from February 2019 to May 2021. MRI parameters included the T1-weighted signal intensity ratio of the pancreas (T1 score), arterial-to-venous enhancement ratio (AVR) during venous and delayed phases, pancreas volume, and diameter. We evaluated the diagnostic performance of these parameters individually and two semi-quantitative MRI scores derived using logistic regression: SQ-MRI Model A (T1 score, AVR venous, and tail diameter) and Model B (T1 score, AVR venous, and volume).
When compared to controls, CP participants showed a significantly lower mean T1 score (1.11 vs. 1.29), AVR venous (0.86 vs. 1.45), AVR delayed (1.07 vs. 1.57), volume (54.97 vs. 80.00 ml), and diameter of the head (2.05 vs. 2.39 cm), body (2.25 vs. 2.58 cm), and tail (1.98 vs. 2.51 cm) (p < 0.05 for all). AUCs for these individual MR parameters ranged from 0.66 to 0.79, while AUCs for the SQ-MRI scores were 0.82 and 0.81 for Model A (T1 score, AVR venous, and tail diameter) and Model B (T1 score, AVR venous, and volume), respectively. After propensity-matching adjustments for covariates, AUCs for Models A and B of the SQ-MRI scores increased to 0.92 and 0.93, respectively.
Semi-quantitative parameters of the pancreatic parenchyma, including T1 score, enhancement ratio, pancreas volume, diameter and multi-parametric models combining these parameters are helpful in diagnosis of CP. Longitudinal analyses including more extensive population are warranted to develop new diagnostic criteria for CP.
确定区分 CP 与对照组的实质 MRI 特征的诊断性能。
本前瞻性研究于 2019 年 2 月至 2021 年 5 月在 7 家机构使用 1.5 T 西门子和 GE 扫描仪对 50 名对照和 51 名明确 CP 参与者进行腹部 MRI 扫描。MRI 参数包括胰腺的 T1 加权信号强度比(T1 评分)、静脉期和延迟期的动脉到静脉增强比(AVR)、胰腺体积和直径。我们评估了这些参数单独以及使用逻辑回归得出的两个半定量 MRI 评分的诊断性能:SQ-MRI 模型 A(T1 评分、静脉 AVR 和尾部直径)和模型 B(T1 评分、静脉 AVR 和体积)。
与对照组相比,CP 组参与者的平均 T1 评分(1.11 与 1.29)、静脉 AVR(0.86 与 1.45)、延迟 AVR(1.07 与 1.57)、体积(54.97 与 80.00 ml)和头部直径(2.05 与 2.39 cm)、体部直径(2.25 与 2.58 cm)和尾部直径(1.98 与 2.51 cm)显著降低(所有 p < 0.05)。这些单个 MRI 参数的 AUC 范围为 0.66 至 0.79,而 SQ-MRI 评分的 AUC 分别为模型 A(T1 评分、静脉 AVR 和尾部直径)和模型 B(T1 评分、静脉 AVR 和体积)的 0.82 和 0.81。在对协变量进行倾向评分匹配调整后,SQ-MRI 评分模型 A 和模型 B 的 AUC 分别增加到 0.92 和 0.93。
胰腺实质的半定量参数,包括 T1 评分、增强比、胰腺体积、直径和结合这些参数的多参数模型,有助于 CP 的诊断。需要进行包括更广泛人群的纵向分析,以制定 CP 的新诊断标准。